Business

China Real Estate Opportunities - China growth ...

China Real Estate Opportunities - China growth ....

articleCreo Medical Group PlcSeptember 19, 20083/company/creo-medical-group-plc/news/china-real-estate-opportunities-china-growth
China Real Estate Opportunities - China growth ...

About this update from Creo Medical Group Plc

[{"type":"text","content":"\n \n\n\n\nAbout China Real Estate Opportunities\n\nCREO is an established Chinese property investor, with seven\nproperties in three of the PRC's leading cities. We expect it to add\nto and unlock the value in its portfolio quite rapidly via active\nmanagement, refurbishment and development. The seven properties held\nare diversified by sector and geography. Well-let commercial property\nlocated in Shanghai is supplemented by development projects in that\ncity and elsewhere. These include a logistics park near Beijing's\ninternational airport and a mixed residential, retail and leisure\nscheme on a new marina in Qingdao, China's third largest port and the\nvenue for the Beijing Olympics sailing competition.\n\nTo view the latest research report, please visit Edison's website:\n\n\nhttp://www.edisoninvestmentresearch.co.uk/research/category/China%20Real%20Estate%20Opportunities\n\n\nAbout Edison Investment Research\n\nEdison is Europe's leading independent investment research company,\nand winner of \"Best Research\" at the 2007 AIM Awards. With a team of\n50 including over 30 analysts supported by a department of\nsupervisory analysts, editors and assistants, Edison writes on more\nthan 200 companies across every sector. Working directly with\ncorporates, investment banks and fund managers, Edison's research is\nread by every major institutional investor in the UK, as well as by\nthe private client broker and international investor communities.\nEdison was founded in 2003 and is authorised and regulated by the\nFinancial Services Authority.\n\n\nAnalyst contact details\n\nRoger Leboff\[email protected]\n020 3077 5700\n\n\n\n\n\n\n \n ","length":1763,"tagName":"div"}]

More updates from Creo Medical Group Plc